Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Germany
11 of 56 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Aachen, Augsburg, Berlin, Bochum, Bremen, Bremenhaven, Cologne, Dortmund, Dresden, Göttingen, Halle, Hamburg, Hanover, Heidenheim, Kassel, Koblenz, Konstanz, Leipzig, Magdeburg, Mannheim, Marburg, Moers, Munich, Neumünster, Rostock, Schorndorf, Stolberg, Stuttgart, Wiesbaden, Zwickau
- Age
- 18 years to 130 years
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - No phaseTaking peopleIvosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study
- Where
- Augsburg, Bad Liebenwerda, Bad Mergentheim, Bamberg, Berlin, Dresden, Essen, Freiburg im Breisgau, Hanover, Hof, Mönchengladbach, München, Passau, Rheine, Rosenheim, Weinheim
- Age
- 18 years and over
- People
- 100
- Run by
- iOMEDICO AG
See details and how to joinNCT06607302 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Aachen, Halle, Saarbrücken
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleNIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
- Where
- Düsseldorf
- Age
- 18 years and over
- People
- 350
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT07365930 - Phase 4Taking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Heidelberg, Munich
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseTaking peoplePrediction of Decompensation and HCC Development in Advanced Chronic Liver Disease
- Where
- Münster
- Age
- 18 years and over
- People
- 600
- Run by
- University Hospital Muenster
See details and how to joinNCT06523608 - No phaseTaking peopleMultiparametric MRI for Characterization of Hepatocellular Carcinoma
- Where
- Münster
- Age
- 18 years and over
- People
- 128
- Run by
- University Hospital Muenster
See details and how to joinNCT06999174 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Hanover, Munich, Tübingen
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Aachen, Berlin, Freiburg im Breisgau, Mainz, Würzburg
- Age
- 18 years to 100 years
- People
- 10,000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseTaking peopleProspective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
- Where
- Munich
- Age
- 18 years and over
- People
- 100
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT03253536